通过代谢学研究,通过比较双极性障碍不同临床阶段的代谢途径
Qin Guo1, Jiao Jia1, Xiao Li Sun2
1Shanxi Bethune Hospital, Shanxi Medical University, Taiyuan, Shanxi, China.
Frontiers in psychiatry
|January 24, 2024
概括
这项研究发现了双极性障碍 (BD) 临床阶段的共同代谢途径,确定了抑郁,躁狂和混合发作的特定生物标志物. 这些发现有助于BD类型和理解其分子基础.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 代谢学 代谢学 代谢学
背景情况:
- 双极性障碍 (BD) 是一种情绪障碍,具有不同的临床阶段,包括抑郁,躁狂/躁狂和混合发作.
- 了解这些阶段之间的潜在代谢差异对于准确的诊断和有针对性的治疗至关重要.
研究的目的:
- 识别与双相情感障碍不同临床阶段相关的不同代谢生物标志物.
- 探索涉及到BD发作病理生理学的共同和特定的代谢途径.
- 为BD表型和分子机制研究提供代谢基础.
主要方法:
- 血清代谢分析分析在患有抑郁症 (BE),躁狂/低躁狂 (BH) 和混合 (BM) 情节的BD患者和健康对照者 (HC) 上进行.
- 部分最小平方分析被用来选显著的代谢生物标志物,使每个组与对照区分开来.
- 进行了代谢途径分析,以确定与已识别的生物标志物相关的生化途径.
主要成果:
- 与HC相比,在BE,BH和BM组中观察到3D-酸和N-乙糖蛋白的显著差异.
- 跨BD阶段的共享代谢途径包括酸盐,糖解/葡萄糖生成和体代谢.
- 针对每个发作类型,确定了特定的代谢物概况:BM的甘氨酸,氨酸和氨酸代谢;抑郁发作的β-葡萄糖,甘,脂质,乳酸和乙酸;BH的瓜尼丁乙酸;以及躁狂和BM发作的酸和酸和酸.
结论:
- 代谢学可以区分双极性障碍的临床阶段.
- 分享和不同的代谢途径有助于不同的BD发作病理生理学.
- 已识别的生物标志物为改善BD类型和对分子机制的理解提供了潜力.
相关概念视频
01:30Bipolar Disorder
67
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
67
01:24Mania and Antimanic Drugs: Overview
181
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
181